Dr. Hamdallah Zedan is Senior Adviser to the Minister of Environment, Egyptian Presidency of the Convention on Biological Diversity and was the Chairman of the National Preparatory Committee of the 2018 United Nations Biodiversity Conference (CBD/COP 14, Sharm El Sheikh, Egypt). He holds BSc. (Pharmacy) and M.Sc. (Microbiology) from Cairo University and Ph.D. (Microbiology) from Montreal University. He held various positions with United Nations and Cairo University.  He is the former UN Assistant Secretary General/ Executive Secretary of the Biodiversity Convention from 1998 to 2005 and former Director of UNEP's Biodiversity, Biotechnology, Biosafety and Genetic Resources programmes from 1984 to 1997. He is Emeritus Professor of Microbiology and Immunology, Cairo University and Former Chairman and current Secretary of the Pharmaceutical Studies Committee Sector, Supreme Council of Universities, Egypt.  From 2007 to 2013, he was the Chairman and Managing Director of the Egyptian Company for Sera, Vaccines and Drugs (VACSERA). He supervised and directed research programmes leading to M.Sc. and Ph.D. for more than 75 candidates and published more than 100 papers in various fields of research covering biodiversity, biosafety and intellectual property rights (IPR), recombinant DNA technology, vaccines and immunological products, microbial enzymes, radio-sterilization, microbial drug resistance, immobilized cell fermentation, mycotoxins, microbial contamination of pharmaceuticals. He is a member of many national and international scientific and advisory committees.

Egyptian Presidency of the UN Biodiversity Conference

Chairman of the Preparatory Committee and National Focal Point of the 2018 United Nations        Biodiversity Conference, Sharm El Sheikh, Egypt.
•  Preparation of the United Nations Report on the Status of Global Genetic Resources.
• Coordination and participation in the preparation of Agenda 21of the United Nations as:
        - Task Manager for Chapter 15 of Agenda 21of the United Nations on the Conservation of Biological Diversity to UN Commission on Sustainable Development (CSD).
        - Member, Task Force on Chapter 16 of Agenda 21 of the United Nations on Biotechnology to CSD
• Preparation and implementation of the first UNEP Strategy and Plan of Action for Biodiversity and Biotechnology.

- Chairman and Managing Director, Egyptian Vaccine and Sera Company
Overall responsibility: Securing adequate supply of vaccines and sera (via local manufacture and importation) for the Egyptian Ministry of Health for the annual national compulsory immunization programme for 2.5 million children.

- Assistant Secretary-General of the United Nations/Executive Secretary of the United Nations Convention on Biological Diversity

- Professor Emeritus Department of Microbiology and Immunology

Bachelor of Pharmacy and Pharmaceutical Chemistry,

Cairo University

Master in Microbiology,

Cairo University

PhD in Microbiology,

University of Montreal, Montreal, Canada

Lecturer (Microbiology), Faculty of Pharmacy, University of Montreal.   

Head, Dept. Microbiology and Immunology, Faculty of Medicine, Aleppo University

Head, Dept. Microbiology and Immunology, Faculty of Pharmacy, AlFateh University

2. Elshimy R, R. A. Khattab, H. Zedan, A.S.Hosny and Tarek H. Elmorsy (2018).Study on prevalence and genetic discrimination of methicillin-resistant Staphylococcus aureus (MRSA) in Egyptian hospitals. Afr. J. Microbiol. Res. 12(27):629 - 646.

7. Sheraba, N.S., A.S. Yassin, M.R. Diab, M.A. Amin and H. Zedan (2014).  Detection of endotoxin producing Gram negative bacteria through an environmental ‎monitoring program applied in an antisera production plant. Egypt. J. Biomed. Sci. 38: 211-224.

11. Salem M.H., G. G. Zhanel, H. Zedan and A. M. Noreddin (2014).   Evaluation of Telavancin, Daptomycin, Tigecycline, Linezolid, and Vancomycin Pharmacodynamics against MRSA Isolates Collected in the Canadian-Ward (CAN-Ward) Surveillance Study: A Monte Carlo Simulation Analysis. The American Association of Pharmaceutical Scientists Annual Meeting, 3-6 November 2014, San Diego, California, USA.

1. Helal H.S., A. Hanora, R. A. Khattab, H. Hamouda and H. Zedan (2018). Mining of Egypt's Red Sea invertebrates for potential bioactive producers.  Biotechnology Letters. https://doi.org/10.1007/s10529-018-2600.  Published on line 17 August 2018.

4. Abdeldayem A, H. Zedan , A. Badr , A. Fahmy , M. Akmal (2016).In vitro evaluation of anticancer activity of 5-fluorouracil and curcumin in single and combined forms against breast and colon cancer cell lines. International Journal of Advanced Research 4(6): 1649-1657.

5. Aboleil A. and Zedan, H. (2015). Synthesis, cloning and expression of a novel pre-‎miniproinsulin analogue gene in Escherichia coli. Journal of Advanced Research 6:663- 667.

6. Sheraba, N.S., A.S. Yassin, M.R. Diab, M.A. Amin and H. Zedan (2015).  Quality control testing for tracking endotoxin producing Gram negative bacteria during ‎the preparation of polyvalent snake antivenom immunoglobulin. ‎PDA J.Pharm.Sci.Tech. 69:499-510.

10. Helal H.S., Salah El-DinT. A., Ali A. E,Hamouda H.H., Zedan H. (2014).  Tobramycin-silver nanocomposite: a new trend of antimicrobials against resistantstrains.  J. Pharm. Biol. Sci. 9(3):54 - 61.

12. Issa A. H., Shaaban, M., H. Zedan, A. Fahmy (2014). Evaluation of the effects of aluminum phosphate and calcium ‎phosphate nanoparticles as adjuvants in vaccinated mice.International Journal of Chemical Engineering and ‎Applications 373-5:367 .

13. Zedan,H., N. El Kholy, A. Barakat, M. Zaki (2014).  Genetic mutations in influenza viruses and its relation to drug resistance.  Ain Shams Univ.J. Environment. Stud. 10: 123-132.

14. Hashem, R., M. Amin and H. Zedan(2013). Fluoroquinolone resistance mechanisms in methicillin-resistant Staphylococcus aureus clinical isolates from two major hospitals in Cairo, Egypt.  Journal of Infection in Developing Countries 7:  796-803.

15. Yassin A. et al (2013). Antibiotic resistance patterns among common Gram positive and Gram negative pathogens in clinical isolates from major hospitals in Cairo, Egypt. In "Worldwide Efforts in Fighting against Microbial pathogens: From Basic Research to Technological Developments", A. Mendez-Vilas (ed.), Brown Walker Press, Florida, pp34-39.

16. Sheraba, N.S., A.S. Yassin, M.R. Diab, M.A. Amin and H. Zedan (2013). Determination of possible sources of endotoxin contamination during different steps of antisera production, Fourth International Scientific Conference of Faculty of Pharmacy, Cairo University, Cairo, Egypt, 24-25 April 2013.

17. Ali, M., H. Zedan and A. Kholafi (2012).Evaluation of viability of BCG vaccine using a conventional count method and MTT assay.  Egypt. J. Biomed. Sci. 36: 151-139

20. Zedan, H. (2005).   The Role of the Convention on Biological Diversity and its Protocol on Biosafety in Fostering the Conservation and Sustainable Use of the World's Biological Wealth for Socio-economic and Sustainable Development.  J. Indust. Microbiol. Biotech. (USA) 32 : 496 -501

26. Zedan, H. (ed.) (2005).  Working together for biodiversity: regional and international initiatives contributing to achieving and measuring progress towards the 2010 target.   UN CBD Technical Publication Series 17, UN CBD Secretariat, Montreal, Canada

27. Zedan, H. (ed.) (2005).    Towards effective protected area systems: An action guide to implement the Convention on Biological Diversity programme of work on protected areas.  UN CBD Technical Publication Series 18, UN CBD Secretariat, Montreal, Canada

28. Zedan, H. (ed.) (2004). Solutions for sustainable mariculture - avoiding the adverse effects of mariculture on biological diversity.  UN CBD Technical Series 12  (January 2004), UN CBD Secretariat, Montreal, Canada, pp54

29. Zedan, H. (ed.) (2004). Technical advice on the establishment and management of a national system of marine and coastal protected areas. UN CBD Technical Series 13 (January 2004), UN CBD Secretariat, Montreal, Canada, pp 43

30. Zedan, H. (ed.) (2004). Biodiversity issues for consideration in planning, establishment and management of protected area sites and networks.   UN CBD Technical Publication Series 15, UN CBD Secretariat, Montreal, Canada 

31. Zedan, H. (2004).  Biodiversity for Food, Nutrition and Health: Double Opportunity or Double Challenge. Faculty Club, McGill University, 13 October 2004, pp 1-10.  

32. Zedan, H. (ed.) (2003). Integrated marine and coastal area management approaches for implementation of the Convention on Biological Diversity.   UN CBD Technical Publication Series 14, UN CBD Secretariat, Montreal, Canada 

33. Zedan, H. (2004).  Biodiversity for Food, Nutrition and Health: Double Opportunity or Double Challenge.  Faculty Club, McGill University, 13 October 2004.

Ph.D fellowship, Monterial, Canada

Medical Research Council, Canada

Scientific Research Council, Canada

Chairman of the Preparatory Committee and National Focal Point for the United Nations Conference on Biological Diversity(January 2017 - December 2018)

Board Member, International Assessment for Agricultural Science and Technology for
  Development (2004-2005).

Board Member, Scientific and Technical Advisory Panel (STAP) of the United Nations Global Environment Facility (GEF) (1998-2005)

Chairman of the Scientific and Technical Committee, National Organization for Research and Control of Biologicals, 2016 - 2019).

Member of the Higher Coordination Committee for Health Sectors, Supreme Council of Universities - 2011-2014 and 2015-2021

Member of the National Committee for Environmental Issues and the Future of Planet Earth, Academy of Scientific Research and Technology, 2016-2019